Sort   by:  
 Page size 
UnknownSerum androgens as prognostic biomarkers in castration-resistant prostate cancer: results from an analysis of a randomized phase III trial.
Not available
S-EPMC5569674 | biostudies-literature
UnknownCabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study.
Not available
S-EPMC4383838 | biostudies-literature
UnknownRadiographic progression-free survival as a response biomarker in metastatic castration-resistant prostate cancer: COU-AA-302 results.
Not available
S-EPMC4881370 | biostudies-literature
UnknownAssociation analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
Not available
S-EPMC6568012 | biostudies-literature
Sort   by:  
 Page size